CCL2 and metabolic syndrome: Previous studies in rodents have shown that knockout of the MCP-1 receptor results in decreased hepatic inflammation and steatosis [44] and decreased adipose tissue macrophages [45], underscoring the importance of SAT MCP-1 in MetS subjects.